Phase I clinical trial of the chimeric monoclonal antibody (c30.6) in patients with metastatic colorectal cancer.
Ward RL, Packham D, Smythe AM, Murray J, Anderson-Stewart P, Kitchen N, Muirhead R, Phillips P, Gray P, Bigg-Wither G, Prabakaran K, Freund J, Fullham M, Rule M, Dalley D, Meagher A, Hawkins NJ, Smith GM.
Ward RL, et al. Among authors: meagher a.
Clin Cancer Res. 2000 Dec;6(12):4674-83.
Clin Cancer Res. 2000.
PMID: 11156219
Clinical Trial.